BioSphere Medical to Present at the 12th Annual Needham Growth Stock Conference
06 Enero 2010 - 3:00PM
Business Wire
BioSphere Medical, Inc. (NASDAQ: BSMD) – the pioneer in
the use of bioengineered microspheres to treat uterine fibroids,
hypervascularized tumors and vascular malformations by a minimally
invasive, image-guided medical procedure called embolotherapy –
announced today that Martin Joyce, its executive vice president and
chief financial officer, is scheduled to present at the 12th Annual
Needham Growth Stock Conference on Thursday, January 14, 2010 at
8:40 a.m. eastern time. The conference will be held at the New York
Palace Hotel in New York City.
The presentation will also be broadcast live over the Internet
via the "Investors" page of the BioSphere Medical Web site at
www.biospheremed.com. To listen to the live event, go to the Web
site at least 15 minutes early to register, download and install
any necessary audio software. A replay of the webcast will be
available at the Company's Web site for 30 days following the
presentation.
About BioSphere Medical, Inc.
BioSphere Medical, Inc. seeks to pioneer and commercialize
minimally invasive diagnostic and therapeutic applications based on
proprietary bioengineered microsphere technology. The Company's
core technologies, patented bioengineered polymers and
manufacturing methods, are used to produce microscopic spherical
materials with unique beneficial properties for a variety of
medical applications. BioSphere's principal focus is the use of its
products for the treatment of symptomatic uterine fibroids using a
procedure called uterine fibroid embolization, or UFE. The
Company's products continue to gain acceptance in this rapidly
emerging procedure, as well as in a number of other new and
established medical treatments.
Biosphere Medical (MM) (NASDAQ:BSMD)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Biosphere Medical (MM) (NASDAQ:BSMD)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Biosphere Medical (MM) (NASDAQ): 0 recent articles
Más de BioSphere Medical, Inc. Artículos de Noticias